Manchester-based clinician-led digital health company, Rinicare, has appointed AI and machine learning specialist Miguel Mendao as its Chief Technology and Data Officer to help further develop its impressive portfolio of AI-driven technologies for healthcare.
Rinicare Managing Director, Anthony Holmes, comments, “Miguel is joining Rinicare at a really exciting time, with the first trial deployment of one of our clinical solutions, STABILITY UO, on the horizon. Our ethos is to deliver effective, AI-driven technology which genuinely solves problems for clinicians and makes patients safer, so it is fantastic to have someone with Miguel’s AI expertise joining us.”
Rinicare’s technology portfolio is focused on clinical risk prediction to improve patient safety and is designed to deliver the support that clinicians need, as well as improving patient care and reducing the burden on care providers. Unlike many health tech products, Rinicare’s solutions have been designed by a multidisciplinary team that combines both clinical and technological expertise.
Miguel brings 20 years of experience across sectors through a mix of in-house senior leadership and agency strategy consulting roles. In recent years, he has focused on building AI teams and product offerings for the EMEA and APAC markets, with companies such as Deloitte Consulting, relativ* K.K., PMSquare Pte Ltd, and AIMIA Group Inc.
Miguel holds a PhD in Artificial Intelligence (Machine Learning & Control Architectures), from the University of Kent, worked as Post Doctoral Research Associate in Artificial Immune Systems at the University of York, and has several journal publications and book contributions.